Since then, a global systematic review of 63 studies from 2024, commissioned by the World Health Organization, also indicated ...

A Japanese research team has discovered a novel global cooperative phenomenon of cell interactions in cervical cancer cells.

Positive preliminary data from the phase 1b/2 trial evaluating Olvi-Vec in small cell lung cancer have been announced.

Yale scientists have discovered a promising way to trigger immune responses against certain tumors, using a lupus-related antibody that can slip, undetected, into "cold" tumors and flip on an immune ...

EVM14 received FDA clearance for clinical trials, marking Everest Medicines’ first in-house developed therapeutic to reach ...

City of Hope, one of the largest and most advanced cancer research and treatment organizations in the U.S. with its National ...

Novel trispecific T cell engager, ZW209, demonstrates potent preclinical efficacy against DLL3-expressing tumors and an ...

Marengo Therapeutics, Inc., a clinical-stage biotechnology company pioneering novel approaches for precision immunotherapy in oncology and autoimmune diseases, will present updated clinical and ...

NIH-supported researchers have developed a new method using a protein from tardigrades to help protect healthy tissue during cancer radiation therapy, showing early promise in lab tests.

A new cancer therapy utilising a genetically modified herpes simplex virus type 1 (HSV-1) offers hope for late-stage patients ...

Oregon State University scientists have developed a highly efficient, uniquely shaped magnetic nanoparticle that could enable ...

RNA cancer vaccines are at the forefront of next-generation cancer immunotherapy, showcasing significant potential.